These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 29725633)
61. Mannose-Binding Lectin and Diabetic Nephropathy in Type 1 Diabetes. Zhao SQ; Hu Z J Clin Lab Anal; 2016 Jul; 30(4):345-50. PubMed ID: 26212019 [TBL] [Abstract][Full Text] [Related]
62. A case of renal sarcoidosis with complement activation via the lectin pathway. Hagiwara S; Ohi H; Eishi Y; Kodama F; Tashiro K; Makita Y; Suzuki Y; Maeda K; Fukui M; Horikoshi S; Tomino Y Am J Kidney Dis; 2005 Mar; 45(3):580-7. PubMed ID: 15754281 [TBL] [Abstract][Full Text] [Related]
63. Increased urinary miR-196a level predicts the progression of renal injury in patients with diabetic nephropathy. An Y; Zhang C; Xu F; Li W; Zeng C; Xie L; Liu Z Nephrol Dial Transplant; 2020 Jun; 35(6):1009-1016. PubMed ID: 30521014 [TBL] [Abstract][Full Text] [Related]
64. Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases. Liu S; Guo Q; Han H; Cui P; Liu X; Miao L; Zou H; Sun G Int Urol Nephrol; 2016 Oct; 48(10):1691-8. PubMed ID: 27272256 [TBL] [Abstract][Full Text] [Related]
65. Glomerular C4d deposition indicates in situ classic complement pathway activation, but is not a marker for lupus nephritis activity. Kim SH; Jeong HJ Yonsei Med J; 2003 Feb; 44(1):75-80. PubMed ID: 12619178 [TBL] [Abstract][Full Text] [Related]
66. Glomerular endothelial activation, C4d deposits and microangiopathy in immunoglobulin A nephropathy. Trimarchi H; Coppo R Nephrol Dial Transplant; 2021 Mar; 36(4):581-586. PubMed ID: 31755918 [TBL] [Abstract][Full Text] [Related]
67. Clinical and Pathological Characteristics of Patients With Nonproteinuric Diabetic Nephropathy. Chang DY; Li MR; Yu XJ; Wang SX; Chen M; Zhao MH Front Endocrinol (Lausanne); 2021; 12():761386. PubMed ID: 34764941 [TBL] [Abstract][Full Text] [Related]
68. Decreased Ficolin-3-mediated Complement Lectin Pathway Activation and Alternative Pathway Amplification During Bacterial Infections in Patients With Type 2 Diabetes Mellitus. Barkai LJ; Sipter E; Csuka D; Prohászka Z; Pilely K; Garred P; Hosszúfalusi N Front Immunol; 2019; 10():509. PubMed ID: 30949171 [TBL] [Abstract][Full Text] [Related]
69. Immunohistochemical study of the C5b-9 complex of complement in human kidneys. Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447 [TBL] [Abstract][Full Text] [Related]
70. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement. Li L; Zhang X; Li Z; Zhang R; Guo R; Yin Q; Yang L; Yue R; Su B; Huang S; Xu H; He C; Liu F J Diabetes Complications; 2017 Jan; 31(1):114-121. PubMed ID: 27838100 [TBL] [Abstract][Full Text] [Related]
71. Local activation of the complement system in endoneurial microvessels of diabetic neuropathy. Rosoklija GB; Dwork AJ; Younger DS; Karlikaya G; Latov N; Hays AP Acta Neuropathol; 2000 Jan; 99(1):55-62. PubMed ID: 10651028 [TBL] [Abstract][Full Text] [Related]
72. Significance of renal biopsy in patients with presumed diabetic nephropathy. Harada K; Akai Y; Sumida K; Yoshikawa M; Takahashi H; Yamaguchi Y; Kubo A; Iwano M; Saito Y J Diabetes Investig; 2013 Jan; 4(1):88-93. PubMed ID: 24843636 [TBL] [Abstract][Full Text] [Related]
73. [Assessment of renal function with intravoxel incoherent motion and diffusion tensor imaging in type 2 diabetic patients]. Chen SN; Wang YC; Feng YL; Gao YT; Ju SS Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(5):346-351. PubMed ID: 29429244 [No Abstract] [Full Text] [Related]
74. Non-diabetic renal disease in type 2 diabetes mellitus: Study of renal - retinal relationship. Prakash J; Gupta T; Prakash S; Bhushan P; Usha ; Sivasankar M; Singh SP Indian J Nephrol; 2015; 25(4):222-8. PubMed ID: 26199473 [TBL] [Abstract][Full Text] [Related]
76. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes. Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y Front Immunol; 2020; 11():2073. PubMed ID: 32983156 [No Abstract] [Full Text] [Related]
78. Complement Alternative Pathway׳s Activation in Patients With Lupus Nephritis. Song D; Guo WY; Wang FM; Li YZ; Song Y; Yu F; Zhao MH Am J Med Sci; 2017 Mar; 353(3):247-257. PubMed ID: 28262211 [TBL] [Abstract][Full Text] [Related]
79. Association of glomerular C4d deposition with various demographic data in IgA nephropathy patients; a preliminary study. Nasri H; Ahmadi A; Rafieian-Kopaei M; Bashardoust B; Nasri P; Mubarak M J Nephropathol; 2015 Jan; 4(1):19-23. PubMed ID: 25657981 [TBL] [Abstract][Full Text] [Related]
80. The lectin-like domain of thrombomodulin ameliorates diabetic glomerulopathy via complement inhibition. Wang H; Vinnikov I; Shahzad K; Bock F; Ranjan S; Wolter J; Kashif M; Oh J; Bierhaus A; Nawroth P; Kirschfink M; Conway EM; Madhusudhan T; Isermann B Thromb Haemost; 2012 Dec; 108(6):1141-53. PubMed ID: 23014597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]